{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:49:27Z","timestamp":1773409767866,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[1992,12,1]],"date-time":"1992-12-01T00:00:00Z","timestamp":723168000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1992,12]]},"DOI":"10.1007\/bf03348808","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T11:38:08Z","timestamp":1396611488000},"page":"801-806","source":"Crossref","is-referenced-by-count":29,"title":["Double-blind controlled trial of progesterone vaginal cream treatment for cyclical mastodynia in women with benign breast disease"],"prefix":"10.1007","volume":"15","author":[{"given":"C.","family":"Nappi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Affinito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Di Carlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Montemagno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,2]]},"reference":[{"key":"BF03348808_CR1","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0140-6736(83)92543-6","volume":"2","author":"JR Wisbey","year":"1983","unstructured":"Wisbey J.R., Kumar S., Mansel R.E., Preece P.E., Pye J.K., Hughes L.E. Natural history of breast pain. Lancet 2: 672, 1983.","journal-title":"Lancet"},{"key":"BF03348808_CR2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0140-6736(86)90825-1","volume":"1","author":"IS Fentiman","year":"1986","unstructured":"Fentiman I.S., Caleffi M., Bram K., Chandary M.A., Hayward J.L. Double blind controlled trial of tamoxifen therapy for mastalgia. Lancet 1: 287, 1986.","journal-title":"Lancet"},{"key":"BF03348808_CR3","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1210\/jcem-44-4-771","volume":"44","author":"R Sitruk-Ware","year":"1977","unstructured":"Sitruk-Ware R., Sterkers N., Mowszowicz I., Mauvais-Jarvis P. Inadeguate corpus luteum function in women with benign breast diseases. J. Clin. Endocrinol. Metab. 44:771, 1977.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03348808_CR4","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/bjs.1800621014","volume":"62","author":"PC England","year":"1975","unstructured":"England P.C., Skinner L.G., Cottrell K.M., Sellwood R.A. Sex hormones in breast disease. Br. J.Surg. 62:806, 1975.","journal-title":"Br. J.Surg."},{"key":"BF03348808_CR5","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/0277-5379(84)90051-8","volume":"20","author":"PV Walsh","year":"1984","unstructured":"Walsh P.V., Bulbrook R.D., Stell P.M., Wang D.Y., McDicken I.W., George W.D. Serum progesterone concentration during the luteal phase in women with benign breast disease. Eur. J. Cancer. Clin. Oncol. 20:1339, 1984.","journal-title":"Eur. J. Cancer. Clin. Oncol."},{"key":"BF03348808_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0277-5379(85)90194-4","volume":"21","author":"GF Read","year":"1985","unstructured":"Read G.F., Bradley S.A., Wilson D.W., George W.D., Griffiths K. Evaluation of luteal-phase salivary progesterone levels in women with benign breast disease or primary breast cancer. Eur. J. Clin. Oncol. 21: 9, 1985.","journal-title":"Eur. J. Clin. Oncol."},{"key":"BF03348808_CR7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF01806008","volume":"6","author":"DY Wang","year":"1985","unstructured":"Wang D.Y., Fentiman I.S. Epidemiology and endocrinology of benign breast disease. Breast Cancer Res. Treat. 6:5, 1985.","journal-title":"Breast Cancer Res. Treat."},{"key":"BF03348808_CR8","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/1097-0142(19840315)53:6<1311::AID-CNCR2820530615>3.0.CO;2-R","volume":"53","author":"S Kumar","year":"1984","unstructured":"Kumar S., Mansel R.E., Hughes L.E., Woodhead J.S., Edwards C.A., Scanlon M.F., Newcombe R.G. Prolactin response to thyrotropin-releasing hormone stimulation and dopaminergic inhibition in benign breast disease. Cancer 53:1311, 1984.","journal-title":"Cancer"},{"key":"BF03348808_CR9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/bjs.1800730406","volume":"73","author":"S Kumar","year":"1986","unstructured":"Kumar S., Mansel R.E., Wilson D.W., Read G.F., Truran P.L., Hughes L.E., Griffiths K. Daily salivary progesterone levels in cyclical mastalgia patients and their controls. Br. J.Surg. 73:260, 1986.","journal-title":"Br. J.Surg."},{"key":"BF03348808_CR10","first-page":"127","volume-title":"Endocrinology of cystic breast disease","author":"G Rannevik","year":"1983","unstructured":"Rannevik G., Doberl A., Gershagen S., Rasmussen T.H., Tobiassen T. Elevated serum concentrations of sex hormone binding globulin in fibrocystic breast disease. In: Angeli A., Bradlow H.L., Dogliotti L. (Eds.), Endocrinology of cystic breast disease. Raven Press, New York, 1983, p. 127."},{"key":"BF03348808_CR11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/00016348409157005","volume":"23","author":"K Carlstrom","year":"1984","unstructured":"Carlstrom K., Doberl A., Gershagen S., Rannevik G., Rasmussen T.H., Tobiassen T. Elevated peripheral levels of androgens and of some steroid sensitive plasma proteine in patients with severe fibrocystic breast disease. Acta Obstet. Gynecol. Scand. (Suppl.) 23:157, 1984.","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"BF03348808_CR12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0015-0282(16)44955-1","volume":"34","author":"RB Greenblatt","year":"1980","unstructured":"Greenblatt R.B., Nezhat C., Ben Nun I. The treatment of benign breast disease with danazol. Fertil. Steril. 34:242, 1980.","journal-title":"Fertil. Steril."},{"key":"BF03348808_CR13","first-page":"373","volume":"2","author":"JK Pye","year":"1985","unstructured":"Pye J.K., Mansel R.E., Hughes L.E. Clinical experience of drug treatments for mastalgia Lancet 2: 373, 1985.","journal-title":"Lancet"},{"key":"BF03348808_CR14","first-page":"87","volume":"35","author":"WC Andrews","year":"1990","unstructured":"Andrews W.C. Hormonal management of fibrocystic disease of the breast. J. Reprod. Med. 35:87, 1990.","journal-title":"J. Reprod. Med."},{"key":"BF03348808_CR15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00006250-197907000-00018","volume":"54","author":"I Ricciardi","year":"1979","unstructured":"Ricciardi I., Ianniruberto A. Tamoxifen-induced regression of benign breast lesion. Obstet. Gynecol. 54:80, 1979.","journal-title":"Obstet. Gynecol."},{"key":"BF03348808_CR16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/j.1879-3479.1980.tb00512.x","volume":"73","author":"MM Shaaban","year":"1980","unstructured":"Shaaban M.M., Morad F., Hassan A-el-R. Treatment of fibrocystic mastopathy by an anti-estrogen, tamoxifen. Int. J. Gynecol. Obstet. 73:348, 1980.","journal-title":"Int. J. Gynecol. Obstet."},{"key":"BF03348808_CR17","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/bjs.1800651015","volume":"65","author":"RE Mansel","year":"1978","unstructured":"Mansel R.E., Preece P.E., Hughes L.E. A double blind trial of the prolactin inhibitor bromocriptine in painful benign breast disease. Br. J. Surg. 65:724, 1978.","journal-title":"Br. J. Surg."},{"key":"BF03348808_CR18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/bmj.1.6158.237","volume":"1","author":"M Blichert-Toft","year":"1979","unstructured":"Blichert-Toft M., Anderson A.N., Henriksen O.B., Migind T. Treatment of mastalgia with bromocriptine: a double blind cross-over study. Br. Med. J. 1: 237, 1979.","journal-title":"Br. Med. J."},{"key":"BF03348808_CR19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0002-9378(86)90421-7","volume":"154","author":"H Vorherr","year":"1986","unstructured":"Vorherr H. Fibrocystic breast disease: Pathophysiology, pathomorphology, clinical picture and management. Am. J. Obstet. Gynecol. 154:161, 1986.","journal-title":"Am. J. Obstet. Gynecol."},{"key":"BF03348808_CR20","first-page":"587","volume":"76","author":"H Ruf","year":"1964","unstructured":"Ruf H., Codaccioni J.L., Serment H. Le norethynodrel dans le syndrome premenstruel et les dysplasies mammaires. Bull. Fed. Gynec. Obstet. Franc. 76:587, 1964.","journal-title":"Bull. Fed. Gynec. Obstet. Franc."},{"key":"BF03348808_CR21","first-page":"575","volume":"43","author":"P Mauvais-Jarvis","year":"1972","unstructured":"Mauvais-Jarvis P. Current therapeutic data concerning mastodynia and benign mastopathy. Therapeutique 43:575, 1972.","journal-title":"Therapeutique"},{"key":"BF03348808_CR22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/bmj.2.5813.585","volume":"2","author":"RL Meyrick","year":"1972","unstructured":"Meyrick R.L., Smith I. Benign breast swelling. Br. Med. J. 2:585, 1972.","journal-title":"Br. Med. J."},{"key":"BF03348808_CR23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF00672829","volume":"225","author":"C Colin","year":"1978","unstructured":"Colin C., Gaspard V., Lambotte R. Relationship of mastodynia with its endocrine envi-roment and treatment in a double blind trial with lyne-strol. Archiv. fur Gynaekologie 225: 7, 1978.","journal-title":"Archiv. fur Gynaekologie"},{"key":"BF03348808_CR24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM197807062990104","volume":"299","author":"DD Bradley","year":"1978","unstructured":"Bradley D.D., Wingerd J., Petitti D.B. Serum high density lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. N. Engl. J. Med. 299:17, 1978.","journal-title":"N. Engl. J. Med."},{"key":"BF03348808_CR25","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1056\/NEJM198103053041002","volume":"304","author":"E Hirnoven","year":"1981","unstructured":"Hirnoven E., Malkonen M., Manninem V. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. N. Engl. J. Med. 304:560, 1981.","journal-title":"N. Engl. J. Med."},{"key":"BF03348808_CR26","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2362.1983.tb00127.x","volume":"30","author":"L Fahraeus","year":"1983","unstructured":"Fahraeus L., Larsson-Cohn U., Wallentin L. L-norgestrel and progesterone have different influences on plasma lipoproteins. Eur. J. Clin. Invest. 30:447, 1983.","journal-title":"Eur. J. Clin. Invest."},{"key":"BF03348808_CR27","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/0002-9378(85)90509-5","volume":"151","author":"VB Ottoson","year":"1985","unstructured":"Ottoson V.B., Johansson B.G., Von Schoultz B. Subtraction of high-density lipoprotein cholesterol during estrogen replacement therapy: comparison between progestogens and natural progesterone. Am. J. Obstet. Gynecol. 151: 746, 1985.","journal-title":"Am. J. Obstet. Gynecol."},{"key":"BF03348808_CR28","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1136\/bmj.298.6678.931","volume":"298","author":"IS McFadyen","year":"1989","unstructured":"McFadyen I.S., Raab G.M., Maclntyre C.C.A., Forrest A.P.M. Progesterone cream for cyclic breast pain. Br. Med. J. 298:931, 1989.","journal-title":"Br. Med. J."},{"key":"BF03348808_CR29","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0015-0282(16)48977-6","volume":"44","author":"WB Maxson","year":"1985","unstructured":"Maxson W.B., Hargrove J.T. Bioavailability of oral micronized progesterone. Fertil. Steril. 44: 622, 1985.","journal-title":"Fertil. Steril."},{"key":"BF03348808_CR30","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0015-0282(16)45439-7","volume":"35","author":"B Villaneuva","year":"1981","unstructured":"Villaneuva B., Casper R.F., Yen S.S.C. Intravaginal administration of progesterone: enhanced after estrogen treatment. Fertil. Steril. 35:433, 1981.","journal-title":"Fertil. Steril."},{"key":"BF03348808_CR31","first-page":"543","volume-title":"Research Reports on Gynecology and Obstetrics. The Parthenon Publishing Group, Carnforth","author":"C Nappi","year":"1989","unstructured":"Nappi C., Mercorio F., Affinito P., Lepore L., Montemagno U. Vaginal administration of natural progesterone in premenopausal women with endometrial hyperplasia. In: Genazzani A.R., Petraglia F. and Volpe A. (Eds.), Research Reports on Gynecology and Obstetrics. The Parthenon Publishing Group, Carnforth, 1989, p. 543."},{"key":"BF03348808_CR32","first-page":"132","volume-title":"Breast carcinoma. Risk and detection","author":"CD Haagensen","year":"1981","unstructured":"Haagensen CD., Bodian C., Haagensen D.E.Jr. Fibrous disease of the breast. In: Breast carcinoma. Risk and detection. W.B. Saunders Company, Philadelphia, 1981, p. 132."},{"key":"BF03348808_CR33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/254337a0","volume":"254","author":"AJW Hsueh","year":"1975","unstructured":"Hsueh A.J.W., Peck E.J., Clark J.H. Progesterone antagonism of the estrogen receptor and estrogen-induced uterine growth. Nature 254: 337, 1975.","journal-title":"Nature"},{"key":"BF03348808_CR34","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1210\/endo-97-4-825","volume":"97","author":"L Tseng","year":"1975","unstructured":"Tseng L., Gurpide E. Induction of human endometrial estradiol dehydrogenase by progestins. Endocrinology 97: 825, 1975.","journal-title":"Endocrinology"},{"key":"BF03348808_CR35","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1210\/endo-114-5-1483","volume":"114","author":"JF Prudhomme","year":"1984","unstructured":"Prudhomme J.F., Malet C., Gompel A., Lalardne J.P., Ochoa C., Boue A., Mauvais-Jarvis P., Kutten F. 17\u03b2-hydroxysteroid dehydrogenase (E2DH) activity in human breast epithelial cell and fibroblast cultures. Endocrinology 114:1483, 1984.","journal-title":"Endocrinology"},{"key":"BF03348808_CR36","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jcem-63-5-1174","volume":"63","author":"A Gompel","year":"1986","unstructured":"Gompel A., Malet C., Spritzer P., Lalardrie J.P., Kutten F., Mauvais-Jarvis P. Progestin effect on cell proliferation and 17\u03b2-hydroxysteroid dehydrogenase activity in normal human breast cells in culture. J. Clin. Endocrinol. Metab. 63:1174, 1986.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03348808_CR37","first-page":"355","volume":"11","author":"R Morville","year":"1982","unstructured":"Morville R., Dray F., Reyner J., Barrat J. Biodisponibilit\u00e9 de la progesterone naturelle admin-istr\u00e9e par voie orale. M\u00e9sure des concentrations du st\u00e9roide dans le plasma, l\u2019endom\u00e8tre et le tissue mammaire. J. Gynecol. Obstet. Biol. Repr. 11:355, 1982.","journal-title":"J. Gynecol. Obstet. Biol. Repr."},{"key":"BF03348808_CR38","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1055\/s-2008-1035875","volume":"47","author":"W Krause","year":"1987","unstructured":"Krause W., Wichmann U., Horn W. Resorption of progesterone through the intact skin of the breast in comparison with other body regions Geburtshilfe Frauenheilkd 47:562, 1987.","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"BF03348808_CR39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/1523-1747.ep12463284","volume":"91","author":"DA Bucks","year":"1988","unstructured":"Bucks D.A., McMaster J.R., Maibach H.I., Guy R.H. Biovailability of topically administered steroids: a \u201cmass balance\u201d technique. J. Invest. Dermatol. 91: 29, 1988.","journal-title":"J. Invest. Dermatol."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03348808.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03348808\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03348808","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T06:32:13Z","timestamp":1565332333000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03348808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,12]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1992,12]]}},"alternative-id":["BF03348808"],"URL":"https:\/\/doi.org\/10.1007\/bf03348808","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,12]]}}}